Loading
Latest filing published 08 Jun 2026 for Vanda Pharmaceuticals Inc..
No signal scores available.
All filings by Charles Cliff Duncan on record concern Vanda Pharmaceuticals Inc. The record holds 2 filings, for trades running from 22 April 2026 to 4 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 8 June 2026 with a share grant in Vanda Pharmaceuticals Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations